New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

AbbVie Inc.

ABBV

Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.

Revenue
+10.3%
EPS
+2,270.0%
Free cash flow
+9.97%
Total debt
+17.7%

Quarter to September 2026, against a year earlier

288.50 4.99 +1.76%
Market cap
$501.2B
P/E
48.8×
Fwd P/E FY26e
37.6×
Dividend yield
2.44%
F-score
8/9
ROIC
20.2%
Net debt / EBITDA
2.6×
Payout ratio
1.2×

AbbVie Inc. (ABBV) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 14 added · 1 removed · 23 modified
P2I1A: no comparison — the Item was not found
8-K Oct 28, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Oct 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 14, 2026 5.02 Departure or appointment of directors or officers
8-K Oct 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 3, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 18, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Aug 4, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 18 added · 2 removed · 32 modified
P2I1A: no comparison — the Item was not found
8-K Jul 31, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 18, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 8, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026 P1I2: 13 added · 33 removed · 35 modified
P2I1A: no comparison — the Item was not found
8-K Apr 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 3, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 4, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 24, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 4 added · 7 removed · 51 modified
1A: 11 added · 22 modified
7: 39 added · 41 removed · 35 modified
8-K Feb 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 7, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 P1I2: 10 added · 1 removed · 28 modified
P2I1A: no comparison — the Item was not found
8-K Oct 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 11, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025 P1I2: 14 added · 1 removed · 28 modified
P2I1A: no comparison — the Item was not found
8-K Jul 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025 P1I2: no comparison — the earlier filing's text is no longer kept
P2I1A: no comparison — the Item was not found
8-K Apr 25, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 3, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024 1: no comparison — no earlier filing on file
1A: no comparison — no earlier filing on file
7: no comparison — no earlier filing on file
8-K Jan 31, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 30, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 25, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 26, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 3, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 5, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.